Hawaii Biotech, Inc. Secures $7.8 Million In Series C Financing

HONOLULU, Hawaii--(BUSINESS WIRE)--Jan. 9, 2006--Hawaii Biotech, Inc., a privately held biopharmaceutical company engaged in the research and development of human pharmaceuticals, announced today that it has raised $7.8 million in a Series C financing round. The round was led by Hawaii Biotech Board Chairman Nick Mitsakos with participation by both Hawaii based and Mainland private investors. As part of the financing, two nationally known figures in the life science arena will join Hawaii Biotech's Board of Directors. The new Board members are:

Back to news